Revision notes โ€บ Foot & ankle

Diabetic foot and Charcot neuroarthropathy

Diabetic foot disease, comprising ulceration, infection, ischaemia and Charcot neuroarthropathy, is a leading cause of hospital admission and amputation in people with diabetes. Early recognition and urgent multidisciplinary care are key, and a hot, swollen foot with intact skin must be considered Charcot until proven otherwise.

Key points

  • Neuropathy, ischaemia, deformity and infection combine to cause diabetic foot ulcers.
  • Active diabetic foot problems need multidisciplinary review within one working day (NICE NG19).
  • Ankle-brachial indices may be falsely normal; toe pressures are more reliable.
  • A positive probe-to-bone test suggests osteomyelitis; MRI is the imaging of choice.
  • A hot swollen foot with intact skin is Charcot until proven otherwise.
  • Charcot is treated with immediate offloading in a total contact cast.
  • Surgery is for unstable deformity, ulceration over prominences or infection, using robust fixation.

The basics

Diabetic foot problems develop from a combination of:

  • Peripheral neuropathy: loss of protective sensation (sensory), muscle imbalance causing clawing and prominent metatarsal heads (motor), and dry, cracked skin (autonomic)
  • Peripheral arterial disease, often distal and calcified
  • Impaired immunity and wound healing
  • Deformity, such as hallux valgus, clawing and prominent bones
  • Trauma, often minor, such as ill-fitting shoes

The typical sequence is neuropathy, unnoticed pressure or trauma, ulceration, then infection, which can lead to osteomyelitis, gangrene and amputation.

The consequences are severe. People with diabetic foot ulcers have high rates of amputation and mortality. Many amputations are preventable with good care.

In the UK, NICE NG19 sets out a structured approach including risk assessment, foot protection services and multidisciplinary foot care services. It emphasises urgent referral of active diabetic foot problems.

Assessment

Assess each foot systematically:

  • Neuropathy: 10 g monofilament testing at several sites, vibration sense with a 128 Hz tuning fork, and ankle reflexes
  • Vascular status: pulses, capillary refill, and Doppler assessment. Ankle-brachial pressure indices can be falsely high in diabetes because of arterial calcification, so toe pressures or waveforms are more reliable
  • Deformity: clawing, bunions, Charcot changes and prominent bony areas
  • Skin: callus, fissures, ulcers, nail problems
  • Infection: redness, warmth, swelling, purulence, probe-to-bone test
  • Footwear

NICE NG19 risk stratifies feet as low, moderate, high or active. Active problems (ulceration, infection, critical ischaemia, gangrene, suspected Charcot) need referral to the multidisciplinary foot care service within one working day.

Ulcers are described by size, depth, site, infection and ischaemia. NICE recommends the SINBAD system for recording ulcer severity. The University of Texas and Wagner classifications are also commonly used. Infection severity is graded using IWGDF or IDSA systems.

Never miss

  • A hot, swollen foot with intact skin in a diabetic patient: suspect Charcot.
  • Gas, abscess or necrotising infection in a diabetic foot needs emergency surgery.
  • Critical limb ischaemia needs urgent vascular assessment.

Common pitfalls

  • Diagnosing cellulitis or gout in a hot neuropathic foot without considering Charcot.
  • Relying on superficial swabs to guide antibiotics.
  • Missing ischaemia because pulses or ABPI seem normal.
  • Allowing weight-bearing in active Charcot.
  • Delaying surgical drainage of a deep foot abscess.

Read the full note (5 more sections) and test yourself

Free for everyone, no card: exam-style questions on diabetic foot and charcot neuroarthropathy with every option explained, real X-rays, and a Consultant on Call to explain anything you get wrong.

Create a free account โ†’ Log in

Further reading: ["NICE NG19. Diabetic foot problems: prevention and management (2015, updated 2019).","International Working Group on the Diabetic Foot (IWGDF) Guidelines (2023).","Eichenholtz SN. Charcot Joints. Springfield: Charles C Thomas, 1966.","Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care 2011."]

โ† All revision notes ยท Question of the day ยท X-ray of the day